Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael Venuti Insider Profile
4 Followers
Michael Venuti, Director at Infinity Pharmaceuticals, holds 56.25K shares in Infinity Pharmaceuticals (Ticker: INFIQ). Most recently, Michael Venuti Sold $6,250 shares of Infinity Pharmaceuticals on Mar 20, 2017 for an estimated value of 21.75K.
Michael Venuti has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Michael Venuti's holdings
Insider Roles
Director
Roles that Michael Venuti holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 20, 2017 - Mar 20, 2018
Return:+25.20%
The most profitable trade made by Michael Venuti
Michael Venuti's Trading History
List of latest transactions for each holding click on a transaction to see Michael Venuti's performance on stock
You May Also Like
Michael Venuti insider profile FAQ
What is the percentage of profitable transactions made by Michael Venuti?
The percentage of profitable transactions made by Michael Venuti is ―.
What is the average return per transaction made by Michael Venuti?
The average return per transaction made by Michael Venuti is ―.
What stocks does Michael Venuti hold?
Michael Venuti holds: INFIQ stocks.
What was Michael Venuti’s latest transaction?
Michael Venuti latest transaction was an Informative Sell of $21.75K.
What was Michael Venuti's most profitable transaction?
Michael Venuti’s most profitable transaction was an Informative Sell of INFIQ stock on March 20, 2017. The return on the trade was 25.20%.
What is Michael Venuti's role in Infinity Pharmaceuticals?
Michael Venuti's role in Infinity Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.